PE70698A1 - Proteina quimerica de union a tnfo para el tratamiento del asma - Google Patents
Proteina quimerica de union a tnfo para el tratamiento del asmaInfo
- Publication number
- PE70698A1 PE70698A1 PE1997000351A PE00035197A PE70698A1 PE 70698 A1 PE70698 A1 PE 70698A1 PE 1997000351 A PE1997000351 A PE 1997000351A PE 00035197 A PE00035197 A PE 00035197A PE 70698 A1 PE70698 A1 PE 70698A1
- Authority
- PE
- Peru
- Prior art keywords
- protein
- moles
- igg
- tnfo
- asthma
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 5
- 108090000623 proteins and genes Proteins 0.000 title abstract 5
- 208000006673 asthma Diseases 0.000 title abstract 2
- 229940027941 immunoglobulin g Drugs 0.000 abstract 4
- 102100040247 Tumor necrosis factor Human genes 0.000 abstract 2
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 abstract 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 abstract 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 abstract 1
- 108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 abstract 1
- 230000000903 blocking effect Effects 0.000 abstract 1
- 102000037865 fusion proteins Human genes 0.000 abstract 1
- 108020001507 fusion proteins Proteins 0.000 abstract 1
- 229950006780 n-acetylglucosamine Drugs 0.000 abstract 1
- 229920001542 oligosaccharide Polymers 0.000 abstract 1
- 150000002482 oligosaccharides Chemical class 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 abstract 1
- 102000003298 tumor necrosis factor receptor Human genes 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
- A61K47/6813—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin the drug being a peptidic cytokine, e.g. an interleukin or interferon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1684296P | 1996-05-08 | 1996-05-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE70698A1 true PE70698A1 (es) | 1998-11-18 |
Family
ID=21779275
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1997000351A PE70698A1 (es) | 1996-05-08 | 1997-05-05 | Proteina quimerica de union a tnfo para el tratamiento del asma |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0910413A2 (fr) |
| JP (1) | JP2000510113A (fr) |
| KR (1) | KR20000010825A (fr) |
| CN (1) | CN1233189A (fr) |
| AR (1) | AR007020A1 (fr) |
| AU (1) | AU725408B2 (fr) |
| BR (1) | BR9708928A (fr) |
| CA (1) | CA2253557A1 (fr) |
| CO (1) | CO4820397A1 (fr) |
| HR (1) | HRP970224A2 (fr) |
| MA (1) | MA24169A1 (fr) |
| PE (1) | PE70698A1 (fr) |
| TR (1) | TR199802238T2 (fr) |
| WO (1) | WO1997041895A2 (fr) |
| ZA (1) | ZA973843B (fr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL136988A0 (en) * | 1997-12-29 | 2001-06-14 | Regeneron Pharma | Novel nucleic acid and polypeptide |
| TR200504220T2 (tr) | 1998-12-17 | 2007-04-24 | Biogen Idec Ma Inc. | Aktif limfotoksin-beta reseptör imunoglobülin şimeAktif limfotoksin-beta reseptör imunoglobülin şimerik proteinlerinin yüksek düzey ifadesi ve saflaştrik proteinlerinin yüksek düzey ifadesi ve saflaştırılması için bir yöntem.ırılması için bir yöntem. |
| US20040220103A1 (en) | 1999-04-19 | 2004-11-04 | Immunex Corporation | Soluble tumor necrosis factor receptor treatment of medical disorders |
| US20010021380A1 (en) * | 1999-04-19 | 2001-09-13 | Pluenneke John D. | Soluble tumor necrosis factor receptor treatment of medical disorders |
| JP4980048B2 (ja) * | 2003-02-28 | 2012-07-18 | アレス トレーディング ソシエテ アノニム | 腫瘍壊死因子結合タンパク質の液体製剤 |
| US7335491B2 (en) * | 2004-08-27 | 2008-02-26 | Wyeth Research Ireland Limited | Production of anti-abeta |
| CN101600450A (zh) | 2006-10-20 | 2009-12-09 | 比奥根艾迪克Ma公司 | 利用可溶性淋巴毒素β受体的脱髓鞘病的治疗 |
| US8338376B2 (en) | 2006-10-20 | 2012-12-25 | Biogen Idec Ma Inc. | Compositions comprising variant LT-B-R-IG fusion proteins |
| EP3488851A1 (fr) * | 2018-10-03 | 2019-05-29 | AVM Biotechnology, LLC | Thérapies immunoablatives |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0939121B2 (fr) * | 1989-09-12 | 2007-12-26 | AHP Manufacturing B.V. | Protéines liant le TNF |
| AU670125B2 (en) * | 1992-09-15 | 1996-07-04 | Immunex Corporation | Method of treating tnf-dependent inflammation using tumor necrosis factor antagonists |
| US5684222A (en) * | 1993-01-22 | 1997-11-04 | Ontario Cancer Institute | Mutant mouse having a disrupted TNFRp55 |
| CA2119089A1 (fr) * | 1993-03-29 | 1994-09-30 | David Banner | Muteines du facteur de necrose tumoral |
| AU3111995A (en) * | 1994-07-22 | 1996-02-22 | F. Hoffmann-La Roche Ag | Pharmaceutical compositions comprising a chimaeric tnf binding protein |
| US5705364A (en) * | 1995-06-06 | 1998-01-06 | Genentech, Inc. | Mammalian cell culture process |
| IL116436A (en) * | 1995-12-18 | 2006-12-31 | Yissum Res Dev Co | Fc?Á-PE CHIMERIC PROTEIN FOR TARGETED TREATMENT OF ALLERGY RESPONSES AND |
-
1997
- 1997-05-02 EP EP97921849A patent/EP0910413A2/fr not_active Withdrawn
- 1997-05-02 HR HR60/016,842A patent/HRP970224A2/xx not_active Application Discontinuation
- 1997-05-02 AU AU27764/97A patent/AU725408B2/en not_active Ceased
- 1997-05-02 CA CA002253557A patent/CA2253557A1/fr not_active Abandoned
- 1997-05-02 KR KR1019980708961A patent/KR20000010825A/ko not_active Withdrawn
- 1997-05-02 JP JP09539522A patent/JP2000510113A/ja active Pending
- 1997-05-02 CN CN97194455A patent/CN1233189A/zh active Pending
- 1997-05-02 TR TR1998/02238T patent/TR199802238T2/xx unknown
- 1997-05-02 MA MA24590A patent/MA24169A1/fr unknown
- 1997-05-02 WO PCT/EP1997/002256 patent/WO1997041895A2/fr not_active Ceased
- 1997-05-02 BR BR9708928-1A patent/BR9708928A/pt not_active Application Discontinuation
- 1997-05-05 PE PE1997000351A patent/PE70698A1/es not_active Application Discontinuation
- 1997-05-05 ZA ZA9703843A patent/ZA973843B/xx unknown
- 1997-05-06 AR ARP970101876A patent/AR007020A1/es not_active Application Discontinuation
- 1997-05-07 CO CO97024335A patent/CO4820397A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2253557A1 (fr) | 1997-11-13 |
| MA24169A1 (fr) | 1997-12-31 |
| WO1997041895A2 (fr) | 1997-11-13 |
| ZA973843B (en) | 1997-11-10 |
| BR9708928A (pt) | 2000-05-09 |
| CN1233189A (zh) | 1999-10-27 |
| AU2776497A (en) | 1997-11-26 |
| KR20000010825A (ko) | 2000-02-25 |
| JP2000510113A (ja) | 2000-08-08 |
| AU725408B2 (en) | 2000-10-12 |
| EP0910413A2 (fr) | 1999-04-28 |
| WO1997041895A3 (fr) | 1998-03-12 |
| HRP970224A2 (en) | 1998-04-30 |
| AR007020A1 (es) | 1999-10-13 |
| CO4820397A1 (es) | 1999-07-28 |
| TR199802238T2 (xx) | 1999-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY25897A1 (es) | Preparación de proteínas de fusión con porciones de inmunoglobulinas | |
| DE69227041D1 (de) | Expression und reinigung von rekombinantem, löslichem gewebefaktor | |
| ATE168415T1 (de) | Wasserlösliche peptidanaloguen mit bindungstellen | |
| RU94045281A (ru) | Иммуноконъюгаты, способ получения иммуноконъюгата, фармацевтическая композиция, применение иммуноконъюгата | |
| SE9100799D0 (sv) | Recombinant human factor viii derivatives | |
| SE8904239L (sv) | Ett rekombinat, humant faktor-viii-derivat | |
| BG102983A (en) | Extramembrane protein 106 polypeptide of moraxella catarrhalis, its gene sequence and application | |
| UA40611C2 (uk) | Імунокон'югат, спосіб його виготовлення, фармацевтична композиція | |
| DE69129865D1 (de) | Osteogene peptide | |
| PE70698A1 (es) | Proteina quimerica de union a tnfo para el tratamiento del asma | |
| DK0871474T4 (da) | Fremstilling af human insulin | |
| EA199800221A1 (ru) | Пептиды антисекреторного фактора, регулирующие патологические изменения проницаемости | |
| DE69030937D1 (de) | Mutanten von Interleukin-3 | |
| RU94045907A (ru) | Вич-антитела человека или их фрагменты, экспрессионные кассеты, клетки-хозяева, фармацевтические композиции, способ защиты | |
| DE69317886D1 (de) | Neue propoxyphenderivate sowie deren protein-und polypeptidlabels und-konjugate | |
| PT833917E (pt) | Moleculas polipeptidicas do estadio pre-eritrocitario do paludismo | |
| AU2002363465A1 (en) | Efficient inhibition of hiv-1 viral entry through a novel fusion protein including of cd4 | |
| CA2126182A1 (fr) | Anticorps humanises reagissant avec le gpiib/iiia | |
| DE69941051D1 (de) | Expression und charakterisierung eines hiv-1 hüllproteins, das mit einer breitreaktiven neutralisier | |
| AU1444699A (en) | Single-chain polypeptides comprising troponin i and troponin | |
| NO20011263L (no) | Moraxella Catarrhalis BASBO34-polypeptider og anvendelser derav | |
| ATE317851T1 (de) | Polypeptide mit aminosäuresequenzen aus dem n- terminalen bereich von gp116 von cytomegalovirus und deren verwendung bei der diagnostik, prophylaxe und therapie | |
| Wines et al. | The Fab/c fragment of IgG produced by cleavage at cyanocysteine residues | |
| HUP0001579A2 (en) | Cell surface molecule mediating cell adhesion and signal transmission | |
| Kim et al. | Construction and characterization of a single-chain immunoglobulin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |